Control-IQ Study: Quality of Life with Type 1 Diabetes in France
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This real-world study looks at how the Control-IQ system (an automated insulin pump with a continuous glucose monitor) affects blood sugar control and quality of life for people with type 1 diabetes in France. If you join, you will use the system as usual and fill out some questionnaires for one year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 1 diabetes, confirmed by a doctor.
- You must already be using the t:slim X2 pump with Control-IQ technology and a Dexcom G6 or G7 sensor.
- You must be at least 6 years old.
- You must live full-time in mainland France and have an email and a mobile phone.
- You or your parent/guardian must agree to use the system for at least 12 months and to share your data and complete questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
This trial tests a program that gives extra support and follow-up to adults with type 1 diabetes who are already using an insulin pump or closed-loop system and feeling stressed or overwhelmed by their condition. The goal is to see if this support helps reduce diabetes-related distress.
This study tests a new automated insulin delivery system (mylife CamAPS FX) for people with type 1 diabetes. It aims to see how well the system works when paired with a Dexcom G6 continuous glucose monitor.
This study observes how well the Control-IQ insulin pump system works for teenagers with type 1 diabetes who exercise at least twice a week. It aims to see if the technology is safe and effective during regular physical activity.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.